Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 10
- Labeller names
- 2
- Live patents
- 0
- Shortage listings
- 6
- Countries
- 0
Alert
Drug shortage listings
6| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44) | Current | Unavailable | 7 Apr 20201 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41) | Current | Available | 7 Apr 20201 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42) | Current | Unavailable | 7 Apr 20201 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Current | Available | 2 Apr 20201 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Current | Available | 2 Apr 20201 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Current | Limited Availability | 2 Apr 20201 Sept 2026 |
Catalogue
Drug listings by form and route
1010 active NDC listings: 10 human prescription drug. By marketing category: ANDA 10.
| Dosage form | NDCs |
|---|---|
| capsule | 5 |
| tablet | 4 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|---|
| oral | 10 |
| Labeller name on the listing | NDCs |
|---|---|
| avet pharmaceuticals inc. | 9 |
| avet pharmaceuticals inc | 1 |
Catalogue
Marketed products
11Showing 10 of 11.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Acyclovir | Acyclovir | capsule, oral | 23155-962ANDA |
| Anastrozole | Anastrozole Tablets | tablet, oral | 23155-857ANDA |
| Celecoxib | Celecoxib | capsule, oral | 23155-963ANDA |
| Celecoxib | Celecoxib | capsule, oral | 23155-964ANDA |
| Celecoxib | Celecoxib | capsule, oral | 23155-965ANDA |
| Celecoxib | Celecoxib | capsule, oral | 23155-966ANDA |
| Letrozole | Letrozole Tablets | tablet, film coated, oral | 23155-875ANDA |
| Midodrine Hydrochloride | midodrine hydrochloride | tablet, oral | 23155-969ANDA |
| Midodrine Hydrochloride | midodrine hydrochloride | tablet, oral | 23155-970ANDA |
| Midodrine Hydrochloride | midodrine hydrochloride | tablet, oral | 23155-971ANDA |
Compare
Other companies listing celecoxib
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Viatris Inc.18 sites · 135 NDC
- Pfizer Inc11 sites · 27 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Apotex Inc.6 sites · 372 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Unichem Laboratories Limited, India5 sites · 272 NDC
- Micro Labs Limited5 sites · 141 NDC
Enquiry
Common questions
- Is Avet Pharmaceuticals Inc. FDA approved?
- Avet Pharmaceuticals Inc. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Avet Pharmaceuticals Inc. make?
- 11 products are listed under Avet Pharmaceuticals Inc. in the openFDA NDC Directory, most often as capsule; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Avet Pharmaceuticals Inc. products in shortage?
- 6 presentations are currently listed in the FDA drug shortage database under Avet Pharmaceuticals Inc., covering Furosemide Injection, Midazolam Hydrochloride Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.